Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
BioEclipse Therapeutics
BioEclipse Therapeutics
City of Hope Medical Center
Rutgers, The State University of New Jersey
Cancer Research UK